Literature DB >> 11936585

TP53 mutations in human meningiomas.

F M Verheijen1, M Sprong, J M E Kloosterman, G Blaauw, J H H Thijssen, M A Blankenstein.   

Abstract

Overexpression of p53 has been reported to play a role in the development of neoplasms of the central nervous system. Meningiomas are generally benign intracranial tumors originating from the meninges. Overexpression of the p53 protein in meningiomas and an association with histological type and recurrence has been reported. Mutation of the TP53 gene leads to a more stable p53 protein in quantities high enough for detection by immunohistochemistry. In the search for these mutations the core domain of the TP53 gene of meningiomas has been analyzed. Only a very low incidence of mutations was reported. The apparent discordance between overexpression of p53 protein and TP53 gene mutations may be explained by mutations located outside the core domain. This issue was addressed in the present study. All 11 exons of 17 meningiomas were analyzed for DNA alterations by PCR single-strand conformation polymorphism (PCR-SSCP) analysis with subsequent sequencing. PCR-SSCP analysis showed a various number of band shifts and nucleotide alterations, caused either by alterations in the flanking introns or common polymorphisms (codon 36 and 72). The allele frequencies of the polymorphisms found in this small population of tumors resemble the frequencies reported in the literature. In addition, three nucleotide changes located in introns 2, 3 and 7 were found in 11, 3 and 4, respectively, of 17 specimens. Based on this study and on reports by others we conclude that it is not very likely that TP53 mutations are involved in the etiology of meningiomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11936585     DOI: 10.5301/jbm.2008.3174

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  9 in total

1.  Atypical molecular background of glioblastoma and meningioma developed in a patient with Li-Fraumeni syndrome.

Authors:  Piotr Rieske; Magdalena Zakrzewska; Wojciech Biernat; Jacek Bartkowiak; Arthur Zimmermann; Paweł Piotr Liberski
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

2.  The p53/p21 DNA damage-signaling pathway is defective in most meningioma cells.

Authors:  Huda H Al-Khalaf; Boleslaw Lach; Ayman Allam; Ahmed AlKhani; Salman A Alrokayan; Abdelilah Aboussekhra
Journal:  J Neurooncol       Date:  2007-01-24       Impact factor: 4.130

3.  Specific genes expressed in association with progesterone receptors in meningioma.

Authors:  Elizabeth B Claus; Peter J Park; Rona Carroll; Jennifer Chan; Peter M Black
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

4.  Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression.

Authors:  Nives Pećina-Šlaus; Anja Kafka; Tomislav Vladušić; Davor Tomas; Monika Logara; Josip Skoko; Reno Hrašćan
Journal:  Int J Exp Pathol       Date:  2016-06-12       Impact factor: 1.925

5.  DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.

Authors:  Francesca Menghi; Francesca N Orzan; Marica Eoli; Mariangela Farinotti; Emanuela Maderna; Federica Pisati; Donatella Bianchessi; Lorella Valletta; Sandro Lodrini; Giuseppe Galli; Elena Anghileri; Serena Pellegatta; Bianca Pollo; Gaetano Finocchiaro
Journal:  Oncologist       Date:  2011-09-23

6.  Loss of heterozygosity of the p53 gene and deregulated expression of its mRNA and protein in human brain tumors.

Authors:  K Rohini; J Mathivanan; P D Antony Herold Prabhu; D K Subbakrishna; M L Gope; B A Chandramouli; S Sampath; B Anandh; R Gope
Journal:  Mol Cell Biochem       Date:  2006-12-16       Impact factor: 3.842

7.  Abundant immunohistochemical expression of dopamine D2 receptor and p53 protein in meningiomas: follow-up, relation to gender, age, tumor grade, and recurrence.

Authors:  G Trott; J F S Pereira-Lima; C G S Leães; N P Ferreira; L M Barbosa-Coutinho; M C Oliveira
Journal:  Braz J Med Biol Res       Date:  2015-03-03       Impact factor: 2.590

8.  Degree of Resection and Ki-67 Labeling Index for Recurring Meningiomas.

Authors:  Richard Menger; David E Connor; Alvin Y Chan; Gary Jain; Anil Nanda
Journal:  Cureus       Date:  2017-11-03

9.  Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in silico prediction of their significance.

Authors:  Anja Bukovac; Anja Kafka; Reno Hrašćan; Tomislav Vladušić; Nives Pećina-Šlaus
Journal:  Mol Clin Oncol       Date:  2019-10-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.